Unveiling the link between physical parameters and safety in cardiac rehabilitation: Longitudinal observational study

Apr 20, 2025 by in CARDIOLOGY Comments Off on Unveiling the link between physical parameters and safety in cardiac rehabilitation: Longitudinal observational study

Highlights • Muscle Strength & Adverse Events: Lower quadriceps strength linked to more rehab complications. • Functional Capacity & Adverse Events: Poor fitness raises adverse event risk during rehab. •…

read more

Can the Charlson comorbidity index help to guide DOAC dosing in patients with atrial fibrillation and improve the efficacy and safety of treatment? A subanalysis of the MAS study

Apr 20, 2025 by in CARDIOLOGY Comments Off on Can the Charlson comorbidity index help to guide DOAC dosing in patients with atrial fibrillation and improve the efficacy and safety of treatment? A subanalysis of the MAS study

Highlights • DOAC treatment in patients with atrial fibrillation is performed with two doses (standard and reduced) selected according to recommended criteria. • The MAS trial demonstrated that the use…

read more

Response to “Five-year risk of all-cause death and cardiovascular events in women with gestational diabetes and hypertensive disorders of pregnancy”

Apr 20, 2025 by in CARDIOLOGY Comments Off on Response to “Five-year risk of all-cause death and cardiovascular events in women with gestational diabetes and hypertensive disorders of pregnancy”

We have extensively reviewed the article titled “Five-year risk of all-cause death and cardiovascular events in women with gestational diabetes and hypertensive disorders of pregnancy” authored by Bucci et al….

read more

Role of biomarkers in early diagnosis and prognosis of cardiac amyloidosis: A systematic review and meta-analysis

Apr 20, 2025 by in CARDIOLOGY Comments Off on Role of biomarkers in early diagnosis and prognosis of cardiac amyloidosis: A systematic review and meta-analysis

Abstract Background Cardiac amyloidosis is characterized by amyloid fibril deposition in the heart, leading to restrictive cardiomyopathy and heart failure. Early diagnosis and monitoring are crucial for effective management. This…

read more

Comparison of left bundle branch area pacing between patients with pacing-induced cardiomyopathy and non-ischemic dilated cardiomyopathy

Apr 20, 2025 by in CARDIOLOGY Comments Off on Comparison of left bundle branch area pacing between patients with pacing-induced cardiomyopathy and non-ischemic dilated cardiomyopathy

Abstract Introduction Left bundle branch area pacing (LBBAP) seems to be an alternative to coronary sinus pacing in patients with non-ischaemic dilated cardiomyopathy (NI-DCM) with left bundle branch block (LBBB)…

read more

Thalassemia and iron overload cardiomyopathy: Pathophysiological insights, clinical implications, and management strategies

Apr 20, 2025 by in CARDIOLOGY Comments Off on Thalassemia and iron overload cardiomyopathy: Pathophysiological insights, clinical implications, and management strategies

Abstract Thalassemia is a hereditary blood disorder characterized by reduced hemoglobin production, leading to chronic anemia. A major complication of thalassemia is iron overload, primarily due to regular blood transfusions…

read more

Doxorubicin and cyclophosphamide mode of chemotherapy–related cardiomyopathy: Review of preclinical model

Apr 20, 2025 by in CARDIOLOGY Comments Off on Doxorubicin and cyclophosphamide mode of chemotherapy–related cardiomyopathy: Review of preclinical model

Abstract Over the past 70 years, there has been extensive research focused on preventing chemotherapy-related cardiovascular complications. However, the current state of cardio-oncology research has raised more questions than answers….

read more
Get Clinical Tree app for offline access